AQR Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.16M | Sell |
|
|||||
|
2025
Q1 | $4.64M | Buy |
|
|||||
|
2024
Q4 | $862K | Buy |
|
|||||
|
2024
Q3 | $489K | Sell |
|
|||||
|
2024
Q2 | $560K | Sell |
|
|||||
|
2024
Q1 | $1.27M | Buy |
|
|||||
|
2023
Q4 | $776K | Buy |
|
|||||
|
2023
Q3 | $357K | Buy |
|
|||||
|
2023
Q2 | $451K | Sell |
|
|||||
|
2023
Q1 | $491K | Sell |
|
|||||
|
2022
Q4 | $641K | Buy |
|
|||||
|
2022
Q3 | $527K | Sell |
|
|||||
|
2022
Q2 | $680K | Buy |
|
|||||
|
2022
Q1 | $413K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $418K | Sell |
|
|||||
|
2020
Q4 | $666K | Sell |
|
|||||
|
2020
Q3 | $634K | Sell |
|
|||||
|
2020
Q2 | $664K | Buy |
|
|||||
|
2020
Q1 | $118K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $74K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $228K | Sell |
|
|||||
|
2017
Q3 | $388K | Buy |
|